Peter Greenleaf $AUPH SEC Form 4 Insider Trading

Peter Greenleaf has filed a total of 3 insider trades in $AUPH since 2021. Their most recent trade was a sale of 126,981 shares, made on Mar 06, 2024. Their largest trade was a sale of 126,981 shares, made on Mar 06, 2024. We estimate that they now own 1.5 million shares of $AUPH, worth an estimated $13.3 million.

Insider Trading at $AUPH

There have been a total of 67 insider trades reported at $AUPH since 2021, with 66,600 shares purchased and 1.7 million shares sold. The most active insider traders in $AUPH stock have been Michael Robert Martin, Neil Solomons, and Robert Bindert Huizinga. The most recent trade was a sale of 4,557 shares reported by Jeffrey Allen Bailey (None), made on Nov 11, 2024.

$AUPH Executives and Stock Owners with Insider Trades

• Michael Robert Martin, Chief Business Officer

• Neil Solomons, Chief Medical Officer

• Robert Bindert Huizinga, EVP of Research

• Joseph M Miller, Chief Financial Officer

• Peter Greenleaf, Chief Executive Officer

• Scott Michael Habig, Chief Commercial Officer

• Stephen P. Robertson, EVP, General Counsel

• Volker Knappertz, EVP, Research and Development

• Massimilano Colao, Chief Commercial Officer

• Matthew Maxwell Donley, EVP, Ops & Strategy

• Matthew Maxwell Donley, Ex VP, Intern'l Operations

• Matthew Maxwell Donley, Ex VP, Internal Operations

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.